TRCT
KALA icon

Tower Research Capital (TRC)’s KALA BIO KALA Stock Holding History

Tower Research Capital (TRC)’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-102
Closed -$7.77K – 5398
2025
Q3 		$7.77K Buy
102
+79
+343% +$39.2K ﹤0.01% 4081
2025
Q2 		$5.44K Buy
23
+19
+475% +$3.71K ﹤0.01% 4192
2025
Q1 		$1.27K Sell
4
-10
-71% -$3.79K ﹤0.01% 4745
2024
Q4 		$4.94K Sell
14
-1
-7% -$315 ﹤0.01% 4374
2024
Q3 		$4.3K Sell
15
-22
-59% -$6.94K ﹤0.01% 4599
2024
Q2 		$13.2K Buy
37
+5
+16% +$1.65K ﹤0.01% 3992
2024
Q1 		$12.9K Sell
32
-55
-63% -$20.4K ﹤0.01% 3434
2023
Q4 		$30.5K Buy
+87
New +$30.8K ﹤0.01% 3414
2023
Q3 		– Sell
-3
Closed -$2.42K – 6098
2023
Q2 		$2.42K Sell
3
-17
-85% -$13.2K ﹤0.01% 5201
2023
Q1 		$15K Buy
20
+18
+900% +$15.7K ﹤0.01% 3791
2022
Q4 		$3K Sell
2
-14
-88% -$5.54K ﹤0.01% 5200
2022
Q3 		$9K Buy
+16
New +$12.6K ﹤0.01% 4662
2022
Q2 		– Sell
-5
Closed -$16K – 6309
2022
Q1 		$16K Sell
5
-10
-67% -$26.2K ﹤0.01% 3757
2021
Q4 		$46K Buy
15
+14
+1,400% +$65K ﹤0.01% 2823
2021
Q3 		$9K Sell
1
-3
-75% -$25.9K ﹤0.01% 4447
2021
Q2 		$49K Buy
4
+3
+300% +$47.2K ﹤0.01% 3041
2021
Q1 		$25K Sell
1
-5
-83% -$97.6K ﹤0.01% 3706
2020
Q4 		$99K Sell
6
-10
-63% -$188K ﹤0.01% 2353
2020
Q3 		$305K Buy
16
+14
+700% +$322K ﹤0.01% 2173
2020
Q2 		$54K Buy
+2
New +$56.7K ﹤0.01% 2980
2020
Q1 		– Sell
-5
Closed -$45K – 3491
2019
Q4 		$45K Buy
5
+3
+150% +$29K ﹤0.01% 1408
2019
Q3 		$16K Buy
+2
New +$24.3K ﹤0.01% 2614
2019
Q2 		– Hold
0
– -$4K – 3983
2019
Q1 		– Sell
-1
Closed -$17.8K – 3174
2018
Q4 		$14K Buy
+1
New +$17.3K ﹤0.01% 2211
2018
Q3 		– Hold
0
– -$4K – 4012
2018
Q2 		– Hold
0
– – – 3137
2018
Q1 		– Hold
0
– -$21K – 3562
2017
Q4 		– Hold
0
– – – 2027
2017
Q3 		– Hold
0
– – – 2886

Other funds holding KALA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tower Research Capital (TRC)'s KALA Position: Q4 2025 in Review

Tower Research Capital (TRC) sold out of KALA BIO (KALA) in Q4 2025, closing a stake of 102 shares — an estimated $7.77K sold.

Tower Research Capital (TRC) first reported a position in KALA in Q4 2018 and held it in 23 quarters. The position peaked at $305K in Q3 2020. 29 funds tracked by Wall St. Rank hold KALA as of Q4 2025.

  • Tower Research Capital (TRC) reported no remaining KALA BIO position as of Q4 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 102 KALA BIO shares in Q4 2025, an estimated $7.77K.
  • Tower Research Capital (TRC) first reported a position in KALA BIO in Q4 2018 and held it in 23 quarters.
  • Tower Research Capital (TRC)'s KALA BIO position peaked at $305K in Q3 2020.
  • 29 funds tracked by Wall St. Rank held KALA BIO as of Q4 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.